NCT02278185 2025-05-11
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
University of Colorado, Denver
Phase 2 Completed
University of Colorado, Denver
Endo Pharmaceuticals
Endo Pharmaceuticals
Endo Pharmaceuticals